ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

July 10, 1981

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981